Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022

SELL
$181.39 - $234.03 $179,757 - $231,923
-991 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$193.69 - $247.03 $191,946 - $244,806
991 New
991 $242,000
Q3 2021

Oct 26, 2021

SELL
$189.29 - $209.69 $247,212 - $273,855
-1,306 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$144.0 - $169.39 $5,040 - $5,928
-35 Reduced 2.61%
1,306 $206,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $183,851 - $221,761
1,341 New
1,341 $222,000
Q1 2019

Apr 17, 2019

SELL
$81.56 - $100.67 $205,286 - $253,386
-2,517 Closed
0 $0
Q4 2018

Feb 06, 2019

SELL
$79.28 - $95.27 $82,371 - $98,985
-1,039 Reduced 29.22%
2,517 $216,000
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $327,737 - $365,927
-3,925 Reduced 52.47%
3,556 $325,000
Q2 2018

Aug 07, 2018

BUY
$79.9 - $89.2 $269,183 - $300,514
3,369 Added 81.93%
7,481 $638,000
Q1 2018

Jun 04, 2018

BUY
$71.51 - $84.69 $294,049 - $348,245
4,112 New
4,112 $343,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Chesapeake Wealth Management Portfolio

Follow Chesapeake Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.